These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 7684858)
61. A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site. Park YH; Ryoo BY; Choi SJ; Yang SH; Kim HT Jpn J Clin Oncol; 2004 Nov; 34(11):681-5. PubMed ID: 15613558 [TBL] [Abstract][Full Text] [Related]
62. Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumour. Taal BG; Veenhof CH; Blijham GH; Neijt JP Neth J Med; 1988 Apr; 32(3-4):204-11. PubMed ID: 3283582 [No Abstract] [Full Text] [Related]
63. Empiric chemotherapy in patients with carcinoma of unknown primary site. Sporn JR; Greenberg BR Am J Med; 1990 Jan; 88(1):49-55. PubMed ID: 2403756 [TBL] [Abstract][Full Text] [Related]
64. Management of cancer from an unknown primary. Armstrong AC; Blackhall FH Expert Opin Pharmacother; 2007 Mar; 8(4):445-55. PubMed ID: 17309339 [TBL] [Abstract][Full Text] [Related]
65. Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinoma. Saad ED; Abbruzzese JL Crit Rev Oncol Hematol; 2002 Feb; 41(2):205-11. PubMed ID: 11856596 [TBL] [Abstract][Full Text] [Related]